🔬 Daré Bioscience Announces Pricing of $6.0 Million
Published by OOPSONLINE.IN · Source: The Manila Times · 1 min read · · Updated
What actually happened
SAN DIEGO, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (Nasdaq: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real-world solutions, today announced that it has entered into a definitive securities purchase agreement with institutional investors for the purchase and sale of 4,379,581 shares of the Company’s common stock (or pre-funded warrants to purchase shares of common stock in lieu thereof), at a price of $1.37 per share of common stock (or $1.3699 per pre-funded warrant) in a registered direct of
Key points
- 14, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc.
- (Nasdaq: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real-world solutions, today announced that it has entered into a definitive securities purchase agreement with institutional investors for the purchase and sale of 4,379,581 shares of the Company’s common stock (or pre-funded warrants to purchase shares of common stock in lieu thereof), at a price of $1.
- 37 per share of common stock (or $1.
- 3699 per pre-funded warrant) in a registered direct of
Summary based on data provided by The Manila Times. Full article available at the original publisher.
- #science
- #bioscience
- #announces